Chennai, Feb 8 (IANS) Indian drug major Dr.Reddy's Laboratories Ltd on Monday said its wholly owned US subsidiary Promius Pharma has got the USFDA... ...https://in.news.yahoo.com/dr-reddys-sernivo-spray-gets-usfda-nod-074804939.html
New Delhi : Drug major Dr Reddy's Laboratories (DRL) on Monday said its US subsidiary Promius Pharma has received USFDA approval to market Sernivo... ...http://profit.ndtv.com/news/corporates/article-dr-reddys-gets-us-regulator-nod-to-market-sernivo-spray-1274940
A dedicated place to get a comprehensive economic update, Interactive tools and to voice your opinions. News pertaining to Markets, Corporates,... ...http://www.finalaya.com/News/Dr-Reddys-arm-receives-USFDA-approval-for-Sernivo-Spray-N449588.aspx
The company is in advanced stage of completing global phase-III trials for 4 out of 9 biosimilar programmes in partnership with the US-based Mylan,... ...http://www.indiainfoline.com/article/news-top-story/biocon-to-seek-usfda-nod-for-biosimilars-116020800024_1.html
The ongoing collapse in commodities is similar to the dotcom bust in 2001, said Shiv Puri, managing director of Singapore-based TVF Capital... ...http://economictimes.indiatimes.com/opinion/interviews/housing-finance-pharma-companies-good-investment-opportunities-shiv-puri-md-tvf-capital-advisors/articleshow/50894635.cms
SORBEAD INDIA is offering a wide...
Miocon is pleased to introduce...